Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,730 across all filing types
Latest filing 2024-03-14 Notice of Dividend Amou…
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
112年度股利金額(董事會決議)
Notice of Dividend Amount Classification · 100% confidence The document text is a detailed table and explanation regarding the company's dividend distribution for the fiscal year 112 (2023). It includes information on cash dividends, stock dividends, retained earnings, and board resolutions related to dividend policy. The content focuses on dividend amounts, distribution dates, and related company policies. This matches the description of a Notice of Dividend Amount, which announces dividend amounts, payment dates, and details for shareholders. The document length is short (2241 characters) and contains specific dividend distribution data rather than a full financial report or announcement of a report publication. Therefore, the appropriate classification is Notice of Dividend Amount (DIV).
2024-03-14 Chinese
113年2月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (美時) providing information about fund loans and endorsement guarantees for the current and previous month, including amounts and limits. It is a short document (613 characters) and contains tabular data about financial exposures but does not include comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure related to financial guarantees and loans rather than a full financial report or announcement of voting results, management changes, or capital updates. Given the nature and length, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2024-03-08 Chinese
113年2月營業收入
Regulatory Filings Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 美時, presented in a tabular format with explanations about accounting standards and reporting practices. It contains no detailed financial statements, management discussion, or comprehensive analysis. The length is short (778 characters), and it appears to be a regulatory or public disclosure of revenue figures rather than a full financial report. There is no indication that this is an annual or interim report, audit report, or earnings release. It is more of a regulatory filing or public information disclosure about revenue figures. Therefore, the best fit is Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2024-03-08 Chinese
113年02月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, general managers, and vice general managers, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on insider share ownership and transactions, with no financial statements, earnings data, or management discussion. There is no indication of an annual report, earnings release, or other financial report. The document is a report of personal share transactions and holdings by company directors and executives, fitting the definition of Director's Dealing (DIRS).
2024-03-07 Chinese
113年02月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabular disclosure of shareholdings by insiders, including directors, senior management, and related parties, showing their current holdings, pledged shares, and related percentages. It includes specific data on share counts and pledges but does not contain financial statements, earnings data, or management discussion. The content focuses on insider shareholdings and pledging status, which aligns with reporting of personal share transactions or holdings by company directors and executives. There is no indication of a full annual or interim report, audit report, or other financial disclosures. The document length is 4483 characters, which is relatively short but contains detailed insider shareholding data. Therefore, the best fitting category is Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades).
2024-03-07 Chinese
公告本公司代理發言人異動
Board/Management Information Classification · 100% confidence The document is a short announcement (747 characters) about a change in the company's agent spokesperson, specifying the old and new persons and the effective date. It does not contain financial data, report content, or regulatory certifications. It is clearly an announcement of a management personnel change, specifically about a spokesperson role adjustment. This fits the category of Board/Management Information (MANG).
2024-02-27 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.